Singh NK - Search Results

1

Advances in Colon-Targeted Drug Delivery Systems: Innovative Strategies for Treating Colonic Disorders and Prospects for the Future.

Singh J, Solanki A, Sikarwar GS, Singh NK. Singh J, et al. Among authors: singh nk. Curr Pharm Biotechnol. 2024 Oct 7. doi: 10.2174/0113892010323922240924053921. Online ahead of print. Curr Pharm Biotechnol. 2024. PMID: 39377403

2

Understanding Mechanisms and Key Factors Influencing Melanogenesis for the Management of Melasma: An Updated Review.

Singh NK, Verma AK, Gupta JK. Singh NK, et al. Curr Pharm Biotechnol. 2024 May 10. doi: 10.2174/0113892010301957240424110023. Online ahead of print. Curr Pharm Biotechnol. 2024. PMID: 38738729

3

A Research Update on Exendin-4 as a Novel Molecule Against Parkinson's Disease.

Singh NK, Singh A, Varshney M, Agrawal R. Singh NK, et al. Among authors: singh a. Curr Mol Med. 2023;23(9):889-900. doi: 10.2174/1566524023666230529093314. Curr Mol Med. 2023. PMID: 37254536 Review.

4

Therapeutic Expedition of Luteolin against Brain-related Disorders: An Updated Review.

Singh NK, Bhushan B, Singh P, Sahu KK. Singh NK, et al. Among authors: singh p. Comb Chem High Throughput Screen. 2024 Apr 24. doi: 10.2174/0113862073303342240409060918. Online ahead of print. Comb Chem High Throughput Screen. 2024. PMID: 38659259

5

Multimodal action of phosphodiesterase 5 inhibitors against neurodegenerative disorders: An update review.

Singh NK, Singh P, Varshney P, Singh A, Bhushan B. Singh NK, et al. J Biochem Mol Toxicol. 2024 Nov;38(11):e70021. doi: 10.1002/jbt.70021. J Biochem Mol Toxicol. 2024. PMID: 39425458 Review.

6

Nuclear Factor Kappa B: A Nobel Therapeutic Target of FlavonoidsAgainst Parkinson's Disease.

Singh NK, Singh A, Mayank. Singh NK, et al. Among authors: singh a. Comb Chem High Throughput Screen. 2024;27(14):2062-2077. doi: 10.2174/0113862073295568240105025006. Comb Chem High Throughput Screen. 2024. PMID: 38243959 Review.

7

Dietary Natural Flavonoids: Intervention for MAO-B Against Parkinson's Disease.

Singh A, Sinha S, Singh NK. Singh A, et al. Among authors: singh nk. Chem Biol Drug Des. 2024 Sep;104(3):e14619. doi: 10.1111/cbdd.14619. Chem Biol Drug Des. 2024. PMID: 39223743 Review.

8

Recent patents in polymer-lipid hybrid nanoparticles technology.

Verma J, Singh NK, Bansal KK. Verma J, et al. Among authors: singh nk. Ther Deliv. 2024;15(7):489-493. doi: 10.1080/20415990.2024.2363646. Epub 2024 Jul 9. Ther Deliv. 2024. PMID: 38979583 No abstract available.

9

Role of Astrogliosis in the Pathogenesis of Parkinson's Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target.

Bhushan B, Singh NK. Bhushan B, et al. Among authors: singh nk. CNS Neurol Disord Drug Targets. 2024;23(8):1015-1029. doi: 10.2174/0118715273270473231002104610. CNS Neurol Disord Drug Targets. 2024. PMID: 37817521 Review.

10

Quercetin Exhibits α7nAChR/Nrf2/HO-1-Mediated Neuroprotection Against STZ-Induced Mitochondrial Toxicity and Cognitive Impairments in Experimental Rodents.

Singh NK, Garabadu D. Singh NK, et al. Neurotox Res. 2021 Dec;39(6):1859-1879. doi: 10.1007/s12640-021-00410-5. Epub 2021 Sep 23. Neurotox Res. 2021. PMID: 34554409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,190 results

Search Page

Filters